SPX3 Antibody

What is SPX3 and what biological functions does it regulate?

In plants like Medicago, SPX3 functions as a phosphate-sensing protein that works together with SPX1 to control phosphate homeostasis. These proteins play dual roles: they enhance phosphate starvation responses under low phosphate conditions and inhibit these responses when phosphate is abundant. Additionally, they regulate fungal colonization and arbuscule degeneration in mycorrhizal symbiosis .

It's important to note that the commercial antibody referenced in search results (ab236413) targets human SPANXN3 (abbreviated as SPXN3), which is a distinct protein associated with the X chromosome in sperm nuclei . This highlights the importance of confirming target specificity when selecting antibodies for your research.

What types of SPX3 antibodies are currently available for research applications?

Based on the available information, researchers have access to mouse monoclonal antibodies targeting SPXN3, such as clone OTI1B2 (ab236413). This antibody has been validated for Western blot applications with human samples and was generated using recombinant full-length protein corresponding to human SPANXN3 . For plant SPX3 research, specialized antibodies would need to be developed or sourced from specialized suppliers focusing on plant biology.

How can I verify SPX3 antibody specificity before proceeding with experiments?

Verification of antibody specificity is crucial before designing extensive experiments. Based on standard protocols, researchers should:

• Perform Western blot analysis comparing samples with known SPX3 expression patterns

• Include appropriate positive and negative controls in your validation (such as transfected versus non-transfected cells as shown in product validation data)

• Consider using genetic models with SPX3 knockouts or mutations as negative controls

• Validate across multiple experimental techniques when possible

For plant SPX3 research, verification could involve comparing wild-type plants with spx3 mutants, as described in the Medicago studies .

What is the optimal protocol for using SPX3 antibodies in Western blot applications?

For Western blot applications using anti-SPXN3 antibody [OTI1B2], the recommended dilution is 1/2000. The predicted band size for human SPXN3 is approximately 16 kDa. Validation tests have been conducted using HEK-293T cell lysates transfected with pCMV6-ENTRY SPXN3 cDNA .

A comprehensive Western blot protocol should include:

• Proper sample preparation (cell/tissue lysis and protein extraction)

• SDS-PAGE separation (using an appropriate percentage gel for 16 kDa proteins)

• Transfer to membrane (PVDF or nitrocellulose)

• Blocking (typically 5% non-fat milk or BSA)

• Primary antibody incubation (1/2000 dilution)

• Washing steps

• Secondary antibody incubation

• Detection using chemiluminescence or other appropriate methods

How can I incorporate SPX3 antibodies into immunoprecipitation protocols for interaction studies?

For interaction studies involving SPX3, researchers can implement a fast and economical immunoprecipitation (IP) protocol combined with Single-Pot solid-phase sample preparation (SP3) in a 96-well plate format. This approach offers significant advantages over traditional methods:

• Protein complexes are captured using antibodies and magnetic beads conjugated with protein A

• Samples undergo on-bead digestion using SP3 methodology

• The entire IP-SP3 workflow can be completed in a single day, considerably faster than classical approaches

• The protocol maintains sensitivity while improving throughput capability

This methodology is particularly valuable for large-scale interactome studies to identify proteins that interact with SPX3 in different conditions.

How can SPX3 antibodies help investigate phosphate sensing mechanisms in plants?

For plant biology researchers, SPX3 antibodies can be powerful tools to study phosphate homeostasis mechanisms. Based on findings in Medicago, strategic experiments could include:

• Immunolocalization studies to visualize SPX3 protein distribution in root tissues, particularly in arbuscule-containing cells during mycorrhizal symbiosis

• Co-immunoprecipitation to identify interaction partners of SPX3 under different phosphate conditions

• Quantitative analysis of SPX3 protein levels in wild-type versus mutant plants (spx1, spx3, and spx1spx3 double mutants)

• Correlation studies between SPX3 protein levels and expression of phosphate starvation-induced genes like Mt4 and PT6

These approaches would complement the genetic studies that have demonstrated SPX3's role in phosphate starvation responses and mycorrhizal symbiosis regulation.

What techniques can be used to study SPX3 dynamics in multicellular models rather than simple cell cultures?

To better represent in vivo conditions, researchers can implement multicellular spheroid models rather than traditional monolayer cultures. This approach is particularly valuable when studying protein behavior in complex microenvironments. For SPX3 research, this could involve:

• Generating 3D spheroids from relevant cell types following protocols similar to those described for cancer research

• Analyzing SPX3 distribution throughout the spheroid using immunofluorescence or other antibody-based imaging techniques

• Comparing protein expression and localization patterns between 2D and 3D culture systems

• Examining how microenvironmental factors affect SPX3 function and interaction partners

This approach would provide more physiologically relevant insights into SPX3 biology than traditional monolayer cultures.

How should I analyze SPX3 expression data from mutant studies to understand its functional significance?

Based on the Medicago SPX studies, a comprehensive analysis approach should include:

This type of comprehensive analysis allows for interpretation of both direct and compensatory effects in complex biological systems .

How can I resolve contradictory data when SPX3 appears to have opposite effects under different conditions?

The seeming contradiction in SPX3 function (promoting phosphate responses in low-Pi conditions while inhibiting them in high-Pi conditions) exemplifies the complexity of biological regulatory networks. To resolve such apparent contradictions:

• Design experiments that systematically vary the key environmental parameter (e.g., phosphate concentration gradient)

• Examine protein interactions under different conditions using co-immunoprecipitation with SPX3 antibodies

• Investigate post-translational modifications that might alter SPX3 function

• Analyze the temporal dynamics of SPX3 expression and activity

• Consider the presence of redundant proteins (like SPX1) that may mask phenotypic effects in single mutation studies

Understanding these context-dependent functions requires careful experimental design and appropriate controls at each phosphate concentration level.

How can I adapt SPX3 antibody protocols for high-throughput screening applications?

For high-throughput applications, researchers can implement the 96-well plate format protocol that combines:

• Magnetic bead-based immunoprecipitation

• On-bead digestion using SP3 methodology

• Multi-channel pipette handling for increased throughput

• Standardized washing and elution steps

This approach significantly reduces processing time while maintaining sensitivity, making it ideal for large-scale interaction studies or screening applications .

What are the key considerations when designing SPX3 overexpression experiments to study protein function?

Based on the Medicago SPX studies, researchers should carefully consider:

• The promoter choice - constitutive (like LjUB1) versus tissue-specific (like PT4) promoters yield dramatically different phenotypes

• Single versus multiple gene overexpression (SPX1, SPX3, or both)

• Appropriate controls (empty vector transformed tissues)

• Comprehensive phenotyping approaches including:

  • Visual assessment of morphological changes

  • Molecular markers for relevant processes (e.g., RiEF, PT4, CP3, Chitinase)

  • Physiological measurements (e.g., phosphate concentration)

  • Microscopic analysis of cellular structures

The Medicago studies revealed opposite effects when SPX proteins were expressed from different promoters, highlighting the importance of expression context for protein function interpretation.

What are common pitfalls when using SPX3 antibodies and how can they be addressed?

Common challenges when working with SPX3 antibodies include:

• Cross-reactivity with similar proteins - Validate specificity using appropriate controls including SPX3 knockout samples or competing peptides

• Variable expression levels across tissues - Optimize protein extraction protocols for different tissue types

• Post-translational modifications affecting epitope recognition - Consider using multiple antibodies targeting different regions

• Background signal in immunofluorescence - Implement more stringent blocking and optimize antibody concentration

• Inconsistent results between experiments - Standardize all experimental conditions and use internal controls

How can I troubleshoot contradictory results between protein detection and gene expression data for SPX3?

When protein levels detected by SPX3 antibodies don't match transcript levels:

• Check antibody specificity and ensure it recognizes the specific SPX3 variant present in your system

• Consider post-transcriptional regulation mechanisms that might affect protein stability

• Examine potential post-translational modifications that could affect antibody recognition

• Verify extraction methods are appropriate for the subcellular localization of SPX3

• Implement absolute quantification methods (using recombinant standards) rather than relative comparisons

This comprehensive approach to troubleshooting will help resolve discrepancies between transcript and protein-level data.